Cargando…
Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B
OBJECTIVE: The objective of this study was to explore the risk factors of poor adherence of nucleoside analogs (NUC) treatment in chronic hepatitis B (CHB) patients and the virological changes in patients with poor adherence. SUBJECTS AND METHODS: A total of 205 CHB patients were enrolled. The patie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233945/ https://www.ncbi.nlm.nih.gov/pubmed/30519055 http://dx.doi.org/10.2147/IDR.S186719 |